Top Markets
Coin of the day
Omnimmune Holdings, Inc. Omnimmune Holdings, Inc.

Omnimmune Holdings, Inc.

OMMH
Rank in Stocks #42527
Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as... Omnimmune Holdings, Inc., through its subsidiary, Omnimmune Corp., operates as a development-stage biotechnology company integrating complementary cancer therapeutic, diagnostic, and prognostic technologies in the United States. The company owns rights for monoclonal antibody technologies. It also intends to develop personalized cancer treatment with the selection of prophylactic and therapeutic vaccines (active immunization), monoclonal antibodies (passive immunization), and genomic-based products, which target a hormone called human chorionic gonadotropin. In addition, the company plans to conduct a Phase I trial with its lead candidate anti-human chorionic gonadotropin beta subunit monoclonal antibodies based upon the results of the diagnostic trial. Omnimmune Holdings, Inc. is based in Houston, Texas.
Share Price
$0.0001
Last synced: 2026-07-17
Market Cap
$981.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Omnimmune Holdings, Inc. (OMMH)

Category

Number of shares outstanding for Omnimmune Holdings, Inc. (OMMH)
Number of shares outstanding as of August 2026: 0
According to Omnimmune Holdings, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Omnimmune Holdings, Inc. (OMMH) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
- -
CH
0.00 -
BE
- -
KR